333 reports of this reaction
3.3% of all NALOXONE HYDROCHLORIDE reports
#2 most reported adverse reaction
FATIGUE is the #2 most commonly reported adverse reaction for NALOXONE HYDROCHLORIDE, manufactured by Emergent Devices Inc.. There are 333 FDA adverse event reports linking NALOXONE HYDROCHLORIDE to FATIGUE. This represents approximately 3.3% of all 10,081 adverse event reports for this drug.
Patients taking NALOXONE HYDROCHLORIDE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among NALOXONE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for NALOXONE HYDROCHLORIDE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 333 FDA reports for NALOXONE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.3% of all adverse event reports for NALOXONE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience fatigue while taking NALOXONE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.